Skip to main content
Clinical Trials/NCT02348827
NCT02348827
Unknown
N/A

Family Psychoeducation for Major Depressive Disorder - a Randomized Controlled Trial

Mental Health Services in the Capital Region, Denmark1 site in 1 country100 target enrollmentJanuary 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Major Depressive Disorder
Sponsor
Mental Health Services in the Capital Region, Denmark
Enrollment
100
Locations
1
Primary Endpoint
Number of relpase
Last Updated
10 years ago

Overview

Brief Summary

The aim of the present study is to compare an intervention consisting of Family Psychoeducation (FPE) to an active control intervention of social support for relatives of patients with a diagnosis of major depression.

Detailed Description

More than 50 % of patients experiencing their first depressive episode will have at least one new episode. Therefore, effective interventions to reduce the risk of relapse are. Psychoeducation is an interactive education form enhancing knowledge about patients' illness, including it course, symptoms and treatment. Psychoeducational methods can also act as family intervention which already is an evidence-based practice in schizophrenia and bipolar disorder. In spite of unipolar depression's high prevalence, only few studies have focused on the effect of psychoeducation, including family psychoeducation, in the prevention of new depressive episodes. The aim of the present study is to compare an intervention consisting of Family Psychoeducation (FPE) to an active control intervention of social support for relatives of patients with a diagnosis of major depression. The following hypotheses are proposed: 1. Psychoeducational intervention for relatives will reduces the risk of depressive relapse (defined as a score on The Hamilton six-item subscale, HAM-D6≥7), among remitted depressed patients compared to the control condition 2. Psychoeducational intervention for relatives will shorten time to achieve full symptomatic remission (defined as a score HAM-D6\<5) among partially remitted depressed patients compared to the control condition 3. Psychoeducational intervention for relatives will more effectively reduce depressive symptoms (measured on the HAM-D6) among patients fully symptomatic currently depressed patients, compared to control condition. Secondary aims The study has as a secondary goal to investigate whether a high level of expressed emotion (EE) in relatives at baseline will be associated with poorer outcome, in the form of relapse, in depressed patients.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
September 2017
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Mental Health Services in the Capital Region, Denmark
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age between 18 and 75
  • Major depression diagnosis according to the ICD-10 established by a board certified psychiatrist and verified by the MINI International Neuropsychiatric Interview
  • Living together , or in very regular contact (every day or almost every day), with an adult relative that the patient considers as emotionally important and who are available for intervention
  • Regarding hypothesis 1 and 2, patients will be included if they are in remission or partial remission at the inclusion time defined as a score \<13 on the Hamilton Rating Scale for Depression (HAM-D17) \[20\]. Patients included for the test of hypothesis 3 have a HAM-D17-score \>13 at the time of the inclusion.

Exclusion Criteria

  • Insufficient knowledge of Danish
  • Clinical suspicion of dementia
  • Alcohol, drug or medicine abuse
  • Psychotic symptoms
  • Co-morbidity of severe personality disorder
  • Having undergone ECT treatment during the index depressive episode
  • Maximum duration of the current depressive episode may not exceed 2 years
  • Maximum duration of a period with stable remission may not exceed 3 consecutive months
  • Regarding to the relatives following criteria for participation apply:
  • Inclusion criteria:

Outcomes

Primary Outcomes

Number of relpase

Time Frame: 9 months

The primary outcome is relapse defined as a score ≥ 7 on HAM-D6 \[47\] in the 9-month follow-up period (hypothesis 1) among remitted patients.

Secondary Outcomes

  • Reduction of depressive symptoms(9 months)
  • Time to relapse(Up to 9 months from baseline)

Study Sites (1)

Loading locations...

Similar Trials